These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 25650751)
1. Population-based estimates of the prevalence of uterine sarcoma among patients with leiomyomata undergoing surgical treatment. Mao J; Pfeifer S; Zheng XE; Schlegel P; Sedrakyan A JAMA Surg; 2015 Apr; 150(4):368-70. PubMed ID: 25650751 [No Abstract] [Full Text] [Related]
2. Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma. Brohl AS; Li L; Andikyan V; Običan SG; Cioffi A; Hao K; Dudley JT; Ascher-Walsh C; Kasarskis A; Maki RG Oncologist; 2015 Apr; 20(4):433-9. PubMed ID: 25765878 [TBL] [Abstract][Full Text] [Related]
3. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Parker WH; Fu YS; Berek JS Obstet Gynecol; 1994 Mar; 83(3):414-8. PubMed ID: 8127535 [TBL] [Abstract][Full Text] [Related]
4. [Uterine sarcoma. Clinico-statistical study over 5 years (1963-1967)]. Cargnello U Friuli Med; 1968; 23(6):997-1017. PubMed ID: 5738506 [No Abstract] [Full Text] [Related]
5. FDA warns against procedure used in removing fibroids. Stephenson J JAMA; 2014 May; 311(19):1956. PubMed ID: 24846021 [No Abstract] [Full Text] [Related]
6. Incidence and outcome of occult uterine sarcoma: A multi-centre study of 18604 operations performed for presumed uterine leiomyoma. Yorgancı A; Meydanlı MM; Kadıoğlu N; Taşkın S; Kayıkçıoğlu F; Altın D; Atasoy L; Haberal AN; Kınay T; Akgül MA; Tapısız ÖL; Evliyaoğlu Ö; Tekin ÖM; Fırat Ortaç U; Ayhan A J Gynecol Obstet Hum Reprod; 2020 Jan; 49(1):101631. PubMed ID: 31499285 [No Abstract] [Full Text] [Related]
7. FDA considers restricting or banning laparoscopic morcellation. Brower V J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25313228 [No Abstract] [Full Text] [Related]
8. Systemic hypertension among women with uterine leiomyomata: potential final common pathways of target end-organ remodeling. Silver MA; Raghuvir R; Fedirko B; Elser D J Clin Hypertens (Greenwich); 2005 Nov; 7(11):664-8. PubMed ID: 16278524 [TBL] [Abstract][Full Text] [Related]
9. Medical and socioeconomic impact of uterine fibroids. Greenberg MD; Kazamel TI Obstet Gynecol Clin North Am; 1995 Dec; 22(4):625-36. PubMed ID: 8786874 [No Abstract] [Full Text] [Related]
10. Predictors of leiomyoma recurrence after myomectomy. Hanafi M Obstet Gynecol; 2005 Apr; 105(4):877-81. PubMed ID: 15802421 [TBL] [Abstract][Full Text] [Related]
11. Surgical management of leiomyomata during pregnancy. Burton CA; Grimes DA; March CM Obstet Gynecol; 1989 Nov; 74(5):707-9. PubMed ID: 2812645 [TBL] [Abstract][Full Text] [Related]
12. Survey among German gynecologists on the clinical management of patients with sarcomas of the uterus. Chen FC; David M; Richter R; Muallem MZ; Chekerov R; Sehouli J Anticancer Res; 2013 Aug; 33(8):3375-81. PubMed ID: 23898107 [TBL] [Abstract][Full Text] [Related]
18. [Reflections about the impact caused by the Food and Drug Administration (FDA) warning against uterine and/or fibroid power morcellation]. Brito LG; Rosa e Silva JC; Nogueira AA Rev Bras Ginecol Obstet; 2015 Jul; 37(7):299-301. PubMed ID: 26247248 [No Abstract] [Full Text] [Related]
19. Morcellation of apparent benign uterine myoma: assessing risk to benefit ratio. Bogani G; Chiappa V; Ditto A; Martinelli F; Signorelli M; Lorusso D; Raspagliesi F J Gynecol Oncol; 2016 Jul; 27(4):e37. PubMed ID: 27102246 [No Abstract] [Full Text] [Related]
20. Prospective data collection of a new procedure by a specialty society: the FIBROID registry. Myers ER; Goodwin S; Landow W; Mauro M; Peterson E; Pron G; Spies JB; Worthington-Kirsch R; Obstet Gynecol; 2005 Jul; 106(1):44-51. PubMed ID: 15994616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]